Dengue and chikungunya are viral infections spread by Aedes mosquitoes. These illnesses cause fever, pain, rash, and fatigue.

QDENGA can be administered to individuals irrespective of previous dengue exposure, without requiring pre-vaccination testing ...

LONDON--(BUSINESS WIRE)--Dengue fever, a potentially severe viral illness transmitted by mosquitoes, has experienced a significant upsurge in recent periods and expanded its geographic presence. The ...

India has approved its first dengue vaccine, QDENGA, for people aged 4 to 60 years. Know who can receive it, how the two-dose ...

By Rishika Sadam July 20 (Reuters) - Takeda Pharmaceutical's dengue vaccine Qdenga has been approved by India's drug ...

India approves its first dengue vaccine, QDENGA. Learn who can take it, how effective it is, its WHO approval, eligibility, ...

Universities cannot combat the growing dengue threat alone and called for greater cooperation from surrounding communities ...

A pill to prevent dengue fever—a viral infection also called “breakbone fever” for the severe pain it can cause—could be on the horizon, according to data presented by Johnson & Johnson on Friday, ...

Takeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individuals aged four to sixty years old. QDENGA offers protection ...

India has taken a major step in the fight against dengue after the Central Drugs Standard Control Organisation (CDSCO) approved Takeda's QDENGA (TAK-003), ma ...

July, a 27.8% rise from last year. The BMC has urged residents to prevent mosquito breeding, identify warning symptoms early ...

New Delhi [India], July 20 (ANI): Takeda Biopharmaceuticals India Pvt Ltd. today announced that the Drug Controller General ...